Daily US Times: Chinese pharmaceutical giant Sinopharm has said almost a million people have been given an experimental vaccine dose developed by them as part of an emergency-use program authorized by Beijing.
In an article on social media platform WeChat, citing Chairman Liu Jingzhen, the company said Wednesday that no serious adverse effects have been reported from vaccine recipients so far.
The Chairman of Sinopharm said: “In emergency use, we now have used it on nearly a million people. We have not received any reports of serious adverse reaction, and only a few have some mild symptoms.”
He said the vaccine had been given to Chinese diplomats, construction workers and students who have gone to more than 150 countries around the world during the pandemic — and none of them has reported an infection.
On November 6, Mr Liu said that there were 56,000 people who had received emergency vaccinations and then gone overseas.
Sinopharm had carried out Phase 3 clinical trials involving almost 60,000 people in 10 countries — including the UAE, Peru, Argentina, Bahrain, Egypt and Jordan.
The pharmaceuticals giant has two vaccine candidates and it’s nopt clear which vaccine Liu referred to.
China has granted approval to companies for urgent coronavirus vaccinations using experimental drugs for months. Chinese company CanSino Biologics announced in June that it had been given special authorization to administer its experimental vaccine to the People’s Liberation Army.
You may read: Pfizer applies for first Covid vaccine approval in US